 CAMBRIDGE, Mass., Dec. 22, 2021 GLOBE NEWSWIRE -- Agios Pharmaceuticals, Inc. NASDAQ: AGIO, a leader in the field of cellular metabolism to treat genetically defined diseases, today announced that the company is scheduled to present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 7:30 a.m. ET. 